Home  |  Contact Us  |  Sitemap
 

 
  NEW DRUGS
Centchroman
Centbucridine
Arteether
Bulaquin
Gugulipid
Standardised Herbal Remedy
Isaptent
Centpropazine
Consap
Picroliv
CDRI-99/373
 
  NEW DIAGNOSTICS
Diagnostic Vaccine
Cholera Vaccine
 
  NEW TECHNOLOGY
 
  Other Links
New Facilities
CDRI Publications
Library Holding
Directory
C D R I Tenders
Admin Login
  GUGULIPID (Hypolipidaemic)
 
Click for +zoom       
Gugulipid
...

 

CDRI has developed gugulipid, a cholesterol lowering drug taking the lead from ancient Indian system of medicine, Ayurveda. The Drug has been developed from the plant, Commiphora mukul.

Ayurvedic Practitioners have been utilizing the gum of the tree of Commiphora mukul commonly known as "Gugglu". Ayurvedic literature also mentions the gugglu as a drug for the treatment of goutt, arthritis, rheumatism and lipid disorders.

 

The establishment of promising hypolipidaemic activity in a non-toxic fraction of guggulu led to the identification of the active constituents, gugulsterones. However, as the fraction was equally active as the individual active entities, this fraction designated Gugulipid has been developed as a drug. Gugulipid passed through all the three phases of clinical trials successfully and was found to possess hypolipidaemic activity comparable to the present drug of choice, Clofibrate.
Clinical trials conducted on a large number of patients have clearly indicated the supremacy of gugulipid over other drugs due to absence of any significant side effect. The cholesterol lowering effect is also quite remarkable
The use of Gugulipid led to the average reduction in serum cholesterol and triglycerides by 24% and 22% respectively and there were 80% responders in a group of 330 hyperlipidemic patients. As clofibrate is on the verge of being phased out on account of toxic manifestations, there is a scope for introduction of Gugulipid at international level. The future of this material as a drug will, however, depend on the availability of the plant material.
Drug controller General of India, after the three phases of clinical trials approved the drug for marketing in 1986.

Guggulipid is being manuactured and marketed by Cipla Ltd, Mumbai under the brand name Guglip.

 
 
website copyright © Central Drug Research Institute. All rights reserved.
No part of this should be Downloaded or used in any way other than the non-commercial purposes without prior permission of the Director, CDRI.
Powered by MARG Software Solutions | Contact us
You are Visitor No.
Best viewed at 800 X 600 Resolutions | Internet Explorer 5.0 - Later Version <% if session("iNumber")="" then 'conn.open mydsn Dim rsHits Set rsHits=Server.CreateObject("ADODB.Recordset") rsHits.CursorLocation=adUseClient rsHits.Open "Select visits from Hits", conn, adOpenKeyset, adLockOptimistic session("iNumber")=rsHits("visits") + 1 rsHits("visits")=rsHits("visits") + 1 rsHits.Update rsHits.Close set rsHits=Nothing end if If Len(session("iNumber")) > 0 then 'Display iNumber Response.Write "
" & ConstructDigits(session("iNumber")) & "
" End If '''' Function ConstructDigits(iValue) 'This function accepts a single parameter, iValue, and 'returns HTML containing a series of images representing 'a graphical image of the value in iValue 'Start by ensuring iValue is a number If Not IsNumeric(iValue) then ConstructDigits = iValue & " IS NOT A NUMBER!" Exit Function End If 'Can't show decimals! If InStr(1, iValue, ".") then ConstructDigits = "CANNOT CONTAIN DECIMALS!" Exit Function End If 'Can't show negative numbers! If iValue < 0 then ConstructDigits = "CANNOT DISPLAY NEGATIVE NUMBERS!" Exit Function End If Dim iLoop, strResults For iLoop = (Len(iValue) - 1) to 0 STEP -1 strResults = strResults & "" Next ConstructDigits = strResults End Function '''' %>